Table 1.
Baseline demographics by treatment group.
| Variable | SXB-15 | SXB-22 | ||
|---|---|---|---|---|
| Placebo (n = 60) | All SXB (n = 186) | Placebo (n = 56) | All SXB (n = 112) | |
| Sex, n (%) | ||||
| Male | 17 (28.3) | 66 (35.5) | 24 (42.9) | 56 (50.0) |
| Female | 43 (71.7) | 120 (64.5) | 32 (57.1) | 56 (50.0) |
| Mean (SD) age, years | 40.5 (15.6) | 40.6 (15.3) | 40.9 (13.3) | 37.7 (15.2) |
| Race, n (%) | ||||
| White | 55 (91.7) | 158 (84.9) | 44 (78.6) | 101 (90.2) |
| Black | 3 (5.0) | 22 (11.8) | 11 (19.6) | 7 (6.3) |
| Other | 2 (3.3) | 6 (3.2) | 1 (1.8) | 4 (3.6) |
The “treatment group” indicates the all-treated population. SD = standard deviation; SXB = sodium oxybate.